相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Treatment
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by -TGF antibody to promote durable rejection and immunity in squamous cell carcinomas
E. Dodagatta-Marri et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer
C. G. Kim et al.
ANNALS OF ONCOLOGY (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Regulatory T cells in cancer: where are we now?
Awen Gallimore et al.
IMMUNOLOGY (2019)
Checkpoint blockade in the treatment of breast cancer: current status and future directions
Lironne Wein et al.
BRITISH JOURNAL OF CANCER (2018)
PD-1 Controls Follicular T Helper Cell Positioning and Function
Jingwen Shi et al.
IMMUNITY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
Linda Quatrini et al.
NATURE IMMUNOLOGY (2018)
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara et al.
JAMA ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma
David M. Woods et al.
CLINICAL CANCER RESEARCH (2018)
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
Nicholas A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A.
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes
Kristen S. Purrington et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway
Yong Yu et al.
NATURE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia et al.
CLINICAL CANCER RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer
Ngar-Yee Huen et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Blockade of Programmed Death-1 in Young (New Zealand Black x New Zealand White)F1 Mice Promotes the Suppressive Capacity of CD4+ Regulatory T Cells Protecting from Lupus-like Disease
Maida Wong et al.
JOURNAL OF IMMUNOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
Aleix Prat et al.
ONCOLOGIST (2013)
Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice
Denise Tischner et al.
JOURNAL OF AUTOIMMUNITY (2012)
Molecular mechanisms of Treg-mediated T cell suppression
Angelika Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The Immunosuppressive Tumor Environment Is the Major Impediment to Successful Therapeutic Vaccination in Neu Transgenic Mice
Joseph E. Burgents et al.
JOURNAL OF IMMUNOTHERAPY (2010)
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
Debora Franceschini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation
Sunil K. Chauhan et al.
JOURNAL OF IMMUNOLOGY (2009)
Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
Shawn D. Blackburn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
EJ Wherry et al.
JOURNAL OF VIROLOGY (2003)
Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance
J Shimizu et al.
NATURE IMMUNOLOGY (2002)
CD4+CD25+ immunoregulatory T cells:: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor
RS McHugh et al.
IMMUNITY (2002)
分享论文
